Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

The Toll signaling pathway targets the insulin-like peptide Dilp6 to inhibit growth in Drosophila

ABSTRACT: The Toll signaling pathway targets the insulin-like peptide Dilp6 to inhibit growth in Drosophila

PROVIDER: PRJNA552104 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR9624630_1.fastq.gz	Fastqsanger.gz
	SRR9624630_2.fastq.gz	Fastqsanger.gz
	SRR9624640_1.fastq.gz	Fastqsanger.gz
	SRR9624640_2.fastq.gz	Fastqsanger.gz
	SRR9624650_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 128

Similar Datasets

The Toll signaling pathway targets the insulin-like peptide Dilp6 to inhibit growth in Drosophila

Project description:To identify genes that mediate altered communication between fat body and peripheral tissues, we report the gene expression changes in Drosophila third instar larval fat bodies with or without constitutively-active Toll (Toll10b) to activate innate immune signaling, myristoylated Akt (myrAkt) to activate insulin signaling, or both transgenes to bypass the block from Toll signaling to the upstream part of the insulin signaling pathway

2019-07-02 | GSE133662 | GEO

Transcriptome of insulin signalling associated transcription factor targets

Project description:Transcriptome of insulin signalling associated transcription factor targets

| PRJNA764580 | ENA

The obesity-linked peptide SP16 regulates adipocytes through GIP and insulin receptor

Project description:Obesity has emerged as a global epidemic and represents a major public health concern due to its profound implications for metabolic diseases. While recent pharmacological interventions primarily aim to reduce food intake, enhancing energy expenditure in adipose tissue offers a promising complementary approach. In this study, we identify that SP16, a synthetic α1- antitrypsin derived peptide, is a novel GIP (gastric inhibitory peptide) receptor agonist. SP16 promotes lipolysis via the cAMP pathway, resulting in increased mitochondrial oxygen consumption in adipocytes. Furthermore, SP16 binds to the insulin receptor, and at high concentrations, it attenuates insulin receptor signaling. In diet-induced obese (DIO) mice, acute SP16 treatment improved glucose clearance, elevated circulating free fatty acids, and decreased leptin levels. Ex vivo analyses of epididymal white adipose tissue corroborated these findings, demonstrating enhanced lipolysis in SP16-treated mice. In conclusion, SP16 emerges as a novel lipolytic peptide with beneficial metabolic effects.

2025-08-12 | GSE303737 | GEO

Sustained hyperglycemia specifically targets translation of mRNAs for insulin secretion

Project description:Pancreatic beta-cells are specialized for coupling glucose metabolism to insulin peptide production and secretion. Acute glucose exposure robustly and coordinately increases translation of proinsulin and proteins required for secretion of mature insulin peptide. By contrast, chronically elevated glucose levels that occur during diabetes impair beta-cell insulin secretion and have been shown experimentally to suppress insulin translation. Whether translation of other genes critical for insulin secretion are similarly downregulated by chronic high glucose is unknown. Here, we used high-throughput ribosome profiling and nascent proteomics in MIN6 insulinoma cells to elucidate the genome-wide impact of sustained high glucose on beta-cell mRNA translation. Prior to induction of ER stress or suppression of global translation, sustained high glucose suppressed glucose-stimulated insulin secretion and downregulated translation of not only insulin, but also of mRNAs related to insulin secretory granule formation, exocytosis, and metabolism-coupled insulin secretion. Translation of these mRNAs was also downregulated in primary rat and human islets following ex-vivo incubation with sustained high glucose and in an in vivo model of chronic mild hyperglycemia. Furthermore, translational downregulation decreased cellular abundance of these proteins. Our study uncovered a translational regulatory circuit during beta-cell glucose toxicity that impairs expression of proteins with critical roles in beta-cell function.

2023-12-01 | GSE248349 | GEO

Capicua controls Toll/IL-1 signaling targets independently of RTK regulation

Project description:Capicua controls Toll/IL-1 signaling targets independently of RTK regulation

| PRJNA413960 | ENA

Capicua controls Toll/IL-1 signaling targets independently of RTK regulation

Project description:The HMG-box protein Capicua (Cic) is a conserved transcriptional repressor that functions downstream of receptor tyrosine kinase (RTK) signaling pathways in a relatively simple switch: in the absence of signaling, Cic represses RTK-responsive genes by binding to nearly invariant sites in DNA, whereas activation of RTK signaling downregulates Cic activity, leading to derepression of its targets. This mechanism controls gene expression in both Drosophila and mammals, but whether Cic can also function via other regulatory mechanisms remains unknown. Here we characterize an RTK-independent role of Cic in regulating spatially restricted expression of Toll/IL-1 signaling targets in Drosophila embryogenesis. We show that Cic represses those targets by binding to suboptimal DNA sites of lower affinity than its known consensus sites. This binding depends on Dorsal/NF-kB, which translocates into the nucleus upon Toll activation and binds next to the Cic sites. As a result, Cic binds to and represses Toll targets only in regions with nuclear Dorsal. These results reveal a new mode of Cic regulation unrelated to the well-established RTK-Cic depression axis and implicate cooperative binding in conjunction with low-affinity binding sites as an important mechanism of enhancer regulation. Given that Cic plays a role in many developmental and pathological processes in mammals, our results raise the possibility that some of these Cic functions are independent of RTK regulation and may depend on cofactor-assisted DNA binding.

2018-01-05 | GSE104839 | GEO

Liver macrophages inhibit the endogenous antioxidant response in obesity-associated insulin resistance

Project description:Liver macrophages inhibit the endogenous antioxidant response in obesity-associated insulin resistance

| PRJNA549077 | ENA

Verteporfin targets CCR5 to inhibit TNBC growth and metastasis via YAP1

Project description:Verteporfin targets CCR5 to inhibit TNBC growth and metastasis via YAP1

| PRJNA917518 | ENA

Antigen-specific immunotherapy with a CD4 hybrid insulin peptide neoepitope arrests CD8 T cell differentiation in islet grafts

Project description:Antigen‐specific immunotherapies aim to induce peripheral tolerance in autoreactive T cells without the collateral risks of broad immunosuppression. In type 1 diabetes, certain class II HLA molecules strongly predict disease risk, indicating the centrality of CD4 T cell epitopes in disease. However, CD8 T cells targeting islet-antigens are predominant in human islet infiltrates and critical for disease progression. Understanding how peripheral tolerance induction to CD4 peptide autoantigens can generate the suppression of antigen-specific CD8 T cells is still not entirely understood. Here, we show that nanoparticles conjugated to a single CD4 T cell epitope, a hybrid insulin peptide, can reshape the fate of antigen‐specific CD8 T cells in islet grafts. Induction of tolerance arrested the functional differentiation of antigen-specific CD8 T cells and restricted their TCR repertoire towards a lower‐avidity public TCR. Antigen-specific CD8 T cells are arrested in part by the expansion of interleukin-10 (IL-10)-producing antigen-specific CD4 regulatory populations that function through indirect suppression of dendritic cell licensing in grafts. Neutralization of IL-10 during hybrid insulin peptide tolerance induction abrogates graft protection, restores CD8 effector differentiation and TCR affinity, and rescues dendritic cell licensing, establishing an IL-10 dependent suppression axis. These findings help explain how antigen‐specific therapy to a single CD4 hybrid insulin peptide epitope can arrest autoreactive CD8 T cell effector fates in transplanted islets, prolonging graft survival.

2026-02-02 | GSE299087 | GEO

Transcriptome of insulin signalling associated transcription factor targets

Project description:We report the transcritional targets of transcription factor downstream of insulin signalling. We knocked down transcription factors under reduced insulin signalling in Caenorhabditis elegans and did transcriptom analysis. This study identified target genes interaction complexity in analogous genetic and experimental conditions. It aid in gaining insight into the new molecular mechanisms downstream of rIIS

2021-12-01 | GSE184415 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data